Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Southern Cross Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (263)
Cancellation by sponsor (205)
Prescription medicine registration (22)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2026 (6)
2025 (5)
2024 (16)
2023 (30)
2022 (102)
2021 (29)
2020 (50)
2019 (59)
2018 (35)
2017 (50)
2016 (22)
2015 (17)
2014 (9)
2013 (11)
2012 (19)
2011 (9)
2010 (9)
2009 (13)
2008 (3)
2007 (1)
2003 (1)

Search

Sponsor content

496 result(s) found, displaying 341 to 350

OMEPRAZOLE GENERICHEALTH omeprazole 20 mg enteric-coated tablet bottle Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
TRAMADOL AN SR tramadol hydrochloride 100 mg oral modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
TRAMADOL AN SR tramadol hydrochloride 150 mg oral modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
MORPHINE MR AN morphine sulfate pentahydrate 10 mg modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
MORPHINE MR AN morphine sulfate pentahydrate 30 mg modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
MORPHINE MR AN morphine sulfate pentahydrate 60 mg modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
MORPHINE MR AN morphine sulfate pentahydrate 100 mg modified release tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
LETROZOLE FBM letrozole 2.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

25 June 2019

Cancellation by sponsor

Requested by Southern Cross Pharma Pty Ltd
APREPITANT RMB, APREPITANT SCP (Southern Cross Pharma Pty Ltd)

21 June 2019

Prescription medicine registration

Active ingredients: aprepitant.
Levetiracetam Oral SCP levetiracetam 100 mg/mL amber glass bottle (237434)

8 April 2016

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Levetiracetam Oral SCP levetiracetam 100 mg/mL amber glass bottle.

Pages

First page
Previous page
…
Page 31
Page 32
Page 33
Page 34
Current page 35
Page 36
Page 37
Page 38
Page 39
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.